Nice

Market Access

Can managed access agreements help unlock access through the...

The National Institute for Health and Care Excellence (NICE) process for single technology appraisals (STA) has been established for many years with clear cost effectiveness thresholds.

News

Novartis challenges court ruling allowing use of Avastin in ...

Novartis is appealing against a High Court ruling that it is lawful for the NHS to prescribe Roche’s Avastin (bevacizumab) in an unlicensed use in wet age-related macular degeneration (AMD)

Views & Analysis

Collaboration can ensure access to life-changing innovation

As a pioneering risk sharing scheme has shown, new medications can be the catalyst for a whole new care infrastructure.

News

CSL Behring lung drug would cost NHS £8m per patient, says N...

NICE has rejected CSL Behring’s alpha1-proteinase inhibitor Respreeza for treating genetic emphysema in draft guidance, saying that it would cost a massive £8 million to give a patient a ye

News

Patients call for end to CF drug price row at key meeting

Representatives of NHS England and cystic fibrosis drug company Vertex are to meet on Thursday to try and resolve a two-year impasse over access to life-changing medications.

News

NICE rejects Novartis' CAR-T in adult lymphoma

NICE has said Novartis’ CAR-T therapy Kymriah cannot be funded by the NHS in adults with an aggressive form of lymphoma, calling for further discussions to get the drug on to the market.

Can managed access agreements help unlock access through the...

Novartis challenges court ruling allowing use of Avastin in ...

Collaboration can ensure access to life-changing innovation

CSL Behring lung drug would cost NHS £8m per patient, says N...

Patients call for end to CF drug price row at key meeting

NICE rejects Novartis' CAR-T in adult lymphoma

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Nice

Editor's Picks